Stock Price Quote

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE1626.4561.5 (+3.93 %)
PREV CLOSE ( ) 1564.95
OPEN PRICE ( ) 1558.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 214173
TODAY'S LOW / HIGH ( )1538.85 1635.30
52 WK LOW / HIGH ( )917.7 1727
NSE1625.3059.95 (+3.83 %)
PREV CLOSE( ) 1565.35
OPEN PRICE ( ) 1560.00
BID PRICE (QTY) 1625.30 (128)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 554628
TODAY'S LOW / HIGH( ) 1537.50 1638.00
52 WK LOW / HIGH ( )916.3 1729
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-03 1995
Management Info
Devendra Mehta - Chairman Himanshu Baid - Managing Director
Registered Office

Address 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I I,
New Delhi,
Delhi-110020

Phone 011 - 33550700 / 47317000

Email info@polymedicure.com

Website www.polymedicure.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, NSE, MCX

NEWS

17Jan Poly Medicure informs about board meet
Poly Medicure has informed that a meeting of the Board of Directors of t..
30Apr Poly Medicure informs about disclosure
Poly Medicure has informed that the exchange has received the disclosure..
11Feb Poly Medicure informs about analyst meet
Poly Medicure has informed that an earnings call will be held on friday,..
29Jul Poly Medicure informs about earnings c
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
22Apr Poly Medicure informs about certificate
Pursuant to the regulation 40(9) of SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit614.61790.44
Gross Profit 820.89 2368.26
Operating Profit 1009.643007.64
Net Sales 3208.6410680.45

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Raaj Medisafe India (BSE)
peergroup  51.27 (5.00%)
M.Cap ( in Cr)56.08
Centenial Surgical (BSE)
peergroup  102.30 (2.15%)
M.Cap ( in Cr)37.32
GKB Ophthalmics (BSE)
peergroup  88.10 (0.05%)
M.Cap ( in Cr)44.41
Kretto Syscon (BSE)
peergroup  0.88 (-1.12%)
M.Cap ( in Cr)13.80
Nureca Ltd. (BSE)
peergroup  343.20 (-0.59%)
M.Cap ( in Cr)343.21

Shareholding Pattern

PROMOTERS 53.16%
MUTUAL FUNDS/UTI 4.18%
NON-INSTITUTION 27.29%
FI/BANKS/INSURANCE 1.11%
GOVERNMENT 0%
FII 0%

About Poly Medicure Ltd.

Poly Medicure Ltd. was incorporated in the year 1995. Its today's share price is 1626.45. Its current market capitalisation stands at Rs 15613.43 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10725.88 Cr and Total Income of Rs.11043.32 Cr. The company's management includes Avinash Chandra, Alessandro Balboni, Mukulika Baid, Jugal Kishore Baid, Rishi Baid, Himanshu Baid, Ambrish Mithal, Sonal Mattoo, Amit Khosla, Sandeep Bhargava, Shailendra Raj Mehta, Prakash Chand Surana, Devendra Mehta.

It is listed on the BSE with a BSE Code of 531768 , NSE with an NSE Symbol of POLYMED and ISIN of INE205C01021. It's Registered office is at 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I INew Delhi-110020, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Doogar & Associates, MC Bhandari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.